Patent · US Active

Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

US9480677B2 · kind B2 · utility

4Cited by
55References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2014
Grant dateNov 1, 2016
Priority date
Expiry dateOct 9, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/07
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is directed to the (S)-enantiomer of the compound of formula (I):or a pharmaceutically acceptable solvate or prodrug thereof. This (S)-enantiomer is useful for the treatment of diseases or conditions, such as pain, which are ameliorated or alleviated by the modulation of voltage-gated sodium channels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.